Infectious Disease
News on research and diagnostic development for pathogenic diseases.
UK Government Inks $172.9M Contract With Thriva to Enable COVID-19 Antibody Testing at Home
A two-year contract with blood-based testing firm Thriva will enable capillary blood testing to detect antibodies against SARS-CoV-2 in the UK, according to the government.
DiaSorin Q2 Revenues Rise 20 Percent on SARS-CoV-2 Testing Demand
DiaSorin posted Q2 molecular revenues of €69.4 million, up 23 percent year over year from €56.6 million.
Siemens Healthineers Q3 Diagnostics Revenues Almost Double on Rapid Antigen Test Demand
The firm reported total revenues rose 51 percent year over year to €5.00 billion and said full-year 2021 revenues are expected to be up 17 to 19 percent.
During its annual strategic planning, the firm identified its expanding base of MDx instruments as an essential driver of increasing revenues.
Switch Health, Anven Biosciences Partner on SARS-CoV-2 Test Development
The tests will use a novel class of small molecules, developed by Anven, that have monoclonal antibody-like properties.